Skip to main content

Advertisement

Log in

Processability and Oral Bioavailability Improvement of Itraconazole by Particle Engineering Technique

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The current study aimed to improve the processability and oral bioavailability of itraconazole (ITZ) via spherical agglomeration. ITZ-spherical agglomerates (ITZ-SA) and ITZ-poloxamer 407-spherical agglomerates (ITZ-PLX-SA) were optimized using Box-Behnken design. Here, the drug release was affected by polymer concentration and stirring speed, whereas particle size was altered by stirring speed, polymer concentration, and amount of bridging liquid. Heckel and Kawakita studies showed a reduction in mean yield pressure and remarkably lowered 1/b value than ITZ, indicating better compactibility and flowability of ITZ-PLX-SA. Physicochemical interactions were not observed during the process, as indicated by ATR-FTIR, DSC, and XRPD. The significant improvement in % drug release of ITZ-PLX-SA was attributed to better wettability and the presence of polymer than ITZ-SA and ITZ. The pharmacokinetic study in rats indicated fivefold enhanced Cmax and twofold improved AUC for ITZ-PLX-SA than plain drug. Thus, spherical agglomeration could improve overall processability and pharmacokinetic profile of ITZ.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

Data will be made available on request.

References

  1. Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm. 2011;404:1–9.

    Article  CAS  Google Scholar 

  2. Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:1–10.

    Google Scholar 

  3. Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 2014;9:304–16.

    Article  Google Scholar 

  4. Sowa M, Klapwijk AR, Ostendorf M, Beckmann W. Particle engineering of an active pharmaceutical ingredient for improved micromeritic properties. Chem Eng Technol. 2017;40:1282–92.

    Article  CAS  Google Scholar 

  5. Kawashima Y, Imai M, Takeuchi H, Yamamoto H, Kamiya K, Hino T. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 2003;130:283–9.

    Article  CAS  Google Scholar 

  6. Chatterjee A, Gupta M, Srivastava B. Spherical crystallization: a technique use to reform solubility and flow property of active pharmaceutical ingredients. Int J Pharm Investig. 2017;7:4–9.

    Article  CAS  Google Scholar 

  7. Chen H, Aburub A, Sun CC. Direct compression tablet containing 99% active ingredient—a tale of spherical crystallization. J Pharm Sci. 2019;108:1396–400.

    Article  CAS  Google Scholar 

  8. Maghsoodi M, Nokhodchi A. Agglomeration of celecoxib by quasi emulsion solvent diffusion method: effect of stabilizer. Adv Pharm Bull. 2016;6:607–16.

    Article  CAS  Google Scholar 

  9. Kedia K, Wairkar S. Improved micromeritics, packing properties and compressibility of high dose drug, cycloserine, by spherical crystallization. Powder Technol. 2018;344:665–72.

    Article  Google Scholar 

  10. Nitsure A, Patel D, Wairkar S. Improved processability of ethambutol hydrochloride by spherical agglomeration. Pharm Dev Technol. 2020;25:376–84.

    Article  CAS  Google Scholar 

  11. Chen H, Paul S, Xu H, Wang K, Mahanthappa MK, Sun CC. Reduction of punch-sticking propensity of celecoxib by spherical crystallization via polymer assisted quasi-emulsion solvent diffusion. Mol Pharm. 2020;17:1387–96.

    Article  Google Scholar 

  12. Pitt K, Peña R, Tew JD, Pal K, Smith R, Nagy ZK, et al. Particle design via spherical agglomeration: a critical review of controlling parameters, rate processes and modelling. Powder Technol. 2018;326:327–43.

    Article  CAS  Google Scholar 

  13. Fadke J, Desai J, Thakkar H. Formulation development of spherical crystal agglomerates of itraconazole for preparation of directly compressible tablets with enhanced bioavailability. AAPS PharmSciTech. 2015;16:1434–44.

    Article  CAS  Google Scholar 

  14. Prentice AG, Glasmacher A. Making sense of itraconazole pharmacokinetics. J Antimicrob Chemother. 2005;56:17–22.

    Article  Google Scholar 

  15. Parikh T, Sandhu HK, Talele TT, Serajuddin ATM. Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharm Res. 2016;33:1456–71.

    Article  CAS  Google Scholar 

  16. Gummadi S, Varanasi S. UV spectrophotometric method development and validation for determination of an antifungal agent in bulk and capsules. Samson Isr /J Glob Trends Pharm Sci. 2019;1:11–7.

    Google Scholar 

  17. Kawakita K, Tsutsumi Y. A comparison of equations for powder compression. Bull Chem Soc Jpn. 1966;39:1364–8.

    Article  CAS  Google Scholar 

  18. Jadhav N, Pawar A, Paradkar A. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix. AAPS PharmSciTech. 2007;8:E61–7.

    Google Scholar 

  19. Chavda V, Maheshwari R. Tailoring of ketoprofen particle morphology via novel crystallocoagglomeration technique to obtain a directly compressible material. Asian J Pharm. 2008;2:61.

    Article  Google Scholar 

  20. Maghsoodi M, Taghizadeh O, Martin GP, Nokhodchi A. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int J Pharm. 2008;351:45–54.

    Article  CAS  Google Scholar 

  21. Chow AHL, Leung MWM. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders. Drug Dev Ind Pharm. 1996;22:357–71.

    Article  CAS  Google Scholar 

  22. Teychené S, Sicre N, Biscans B. Is spherical crystallization without additives possible? Chem Eng Res Des. 2010;88:1631–8.

    Article  Google Scholar 

  23. Kawashima Y, Okumura M, Takenaka H. The effects of temperature on the spherical crystallization of salicylic acid. Powder Technol. 1984;39:41–7.

    Article  CAS  Google Scholar 

  24. Maghsoodi M, Derakhshandeh K, Yari Z. On the mechanism of agglomeration in suspension. Adv Pharm Bull. 2012;2:25–30.

    Google Scholar 

  25. Chen K, Hou B, Wu H, Huang X, Li F, Xiao Y, et al. Hollow and solid spherical azithromycin particles prepared by different spherical crystallization technologies for direct tableting. Processes. 2019;7:276.

    Article  CAS  Google Scholar 

  26. Yadav AV, Yadav VB. Preparation and evaluation of polymeric carbamazepin spherical crystals by emulsion solvent diffusion technique. Asian J Pharm. 2009;3:18–25.

    Article  Google Scholar 

  27. Worku ZA, Kumar D, Gomes JV, He Y, Glennon B, Ramisetty KA, et al. Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties. Int J Pharm. 2017;531:191–204.

    Article  CAS  Google Scholar 

  28. Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N. Preparation and in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm. 2008;70:674–83.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors are thankful to Metrochem API Pvt Ltd, Hyderabad, India, for providing a gift sample of itraconazole.

Author information

Authors and Affiliations

Authors

Contributions

Hiral Kapalatiya: data collection, investigation, manuscript writing; Dhrumi Patel: data collection, investigation, data analysis, manuscript writing; Alok D. Singh: data collection, manuscript writing; Sarika Wairkar: conceptualization, methodology designing, supervision, manuscript review. and approval.

Corresponding author

Correspondence to Sarika Wairkar.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 4.34 MB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kapalatiya, H., Patel, D., Singh, A.D. et al. Processability and Oral Bioavailability Improvement of Itraconazole by Particle Engineering Technique. AAPS PharmSciTech 24, 27 (2023). https://doi.org/10.1208/s12249-022-02486-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-022-02486-4

Keywords

Navigation